Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.
Ralph Brandenberger,
Ph.D., to senior vice president, technical operations. Brandenberger joined the Nkarta team in 2018 and oversees the company s cell therapy manufacturing operations.
> Asklepios Biopharmaceutical tapped
Tracy Dowling as general counsel starting Jan. 25. Dowling will help manage and advise on corporate governance, business development transactions, license agreements, employment law and more. Most recently, Dowling served as associate general counsel at Spark Therapeutics.
> Precision oncology specialist OncoDNA signed on
Bernard Courtieu as CEO. Courtieu previously joined IntegraGen as CEO in 2007.
Eduardo Bravo,
OncoDNA s interim CEO since July 2020, will remain a consultant to the company s board.
> Abingdon Health named
Melanie Ross as chief financial officer, effective immediately. Ross will also serve on the company s board. Most recently, she was group finance director at GVO-B1; prior to that, Ross was chief financial office